Name: GLP-3 RT
SKU: 188
Availability: InStock

GLP-3 RT

GLP-3 RT is a synthetic peptide designed as a multi-receptor agonist that interacts with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Because of this triple-receptor activity, it has become a compound of interest in metabolic research focused on energy regulation, glucose metabolism, and hormone signaling pathways.

In preclinical and clinical research environments, GLP-3 RT is commonly studied to explore mechanisms involved in metabolic balance, appetite regulation, and energy expenditure. Its ability to activate multiple hormone-related receptors simultaneously provides researchers with a unique model for examining complex endocrine signaling networks.

Earn up to 399 points.

SKU: N/A Category: PEPTIDES

Description

Product Name:

GLP-3 RT

Synonyms:

LY3437943

Triple Agonist Peptide (GLP-1 / GIP / Glucagon Receptor Agonist)

Content:

5mg / 10mg / 20mg /30mg /50mg per vial

Physical Appearance:

Fine lyophilized powder (white to off-white in appearance)

Molecular Formula:

C₂₂₁H₃₄₂N₄₆O₆₈

Molecular Weight:

~4730 g/mol (approximate)

Purity (HPLC):

≥ 99% (See COA for batch-specific data)

Storage Conditions:

Store refrigerated (2–8 °C). Protect from light and moisture.

Terms:

All products sold by Olympex Solutions are intended strictly for laboratory research, analytical, and in-vitro research purposes only. These products are not intended for human or animal consumption.

Olympex Solutions operates solely as a chemical research supplier and is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Additionally, Olympex Solutions is not classified as an outsourcing facility under Section 503B of the same Act.

The statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Products sold by Olympex Solutions are not intended to diagnose, treat, cure, or prevent any disease.